GNTA

Genenta Science S.p.A. American Depositary Shares (GNTA)

About Genenta Science S.p.A. American Depositary Shares (GNTA)

Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its platform and carries an interferon-alpha payload. The company was founded by Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner on July 24, 2014 and is headquartered in Milan, Italy.

Details

Daily high
$4.37
Daily low
$3.94
Price at open
$3.94
52 Week High
$7.28
52 Week Low
$2.20
Market cap
79.9M
Dividend yield
0.00%
Volume
6,022
Avg. volume
6,091
P/E ratio
-8.25

Genenta Science S.p.A. American Depositary Shares News

Details

Daily high
$4.37
Daily low
$3.94
Price at open
$3.94
52 Week High
$7.28
52 Week Low
$2.20
Market cap
79.9M
Dividend yield
0.00%
Volume
6,022
Avg. volume
6,091
P/E ratio
-8.25